AZ India collaborates with STEMI India

STEMI India and AstraZeneca India will work together to emphasize the importance of the "Golden Hour" and appropriate treatment strategies

aztwitter-400x400

AstraZeneca (AZ) Pharma India (AstraZeneca India) has announced a collaboration with STEMI India Charitable Trust, a not-for-profit organization founded by leading cardiologists Dr Thomas Alexander and Dr Ajit S Mullasari (STEMI India).

Under the collaboration, STEMI India and AstraZeneca India will work together to emphasize the importance of the "Golden Hour" and appropriate treatment strategies across the country for improving the standard of care for heart attack patients.

India has a high burden of coronary artery disease (CAD) in the world; upwards of 3 million heart attacks occur in India every year.

One of the gravest complications of CAD is ST-elevation myocardial infarction (STEMI), a life threatening medical emergency that results from a sudden, occlusive thrombus in the coronary artery.

If treated within 2 hours of onset of symptoms, much of the damage can be controlled and many more lives saved. Current data suggest that patients are brought in to a hospital only after about 300 minutes.

 

Previous 1 3 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X